In the course of shotgun cloning experiments to demonstrate that genes of the cariogenic bacterium Streptococcus mutans PS14 (serotype c) would be functionally expressed in Escherichia coli K-12, we constructed, with restriction endonucleases HindIlI and BamHI, chimeric plasmids that complemented a galKTE deletion (6) . E. coli, like most bacteria, metabolizes galactose via the Leloir pathway: D-galactose D-galactose 1-phosphate -* UDP-D-galactose UDP-D-glucose -* D-glucose 1-phosphate. However, in S. mutans another pathway besides the Leloir pathway can be found (7) . Galactose is phophorylated during phosphoenolpyruvate-dependent phosphotransferase transport of galactose or lactose (3) and is then metabolized through the tagatose phosphate pathway first elucidated in Staphylococcus aureus by Bissett and Anderson (1) and demonstrated for S. mutans by Hamilton and Lebtag (7) : D-galactose 6-phosphate --D-tagatose 6-phosphate -+ tagatose 1,6-diphosphate --D-glyceraldehyde 3- phosphate and dihydroxyacetone phosphate. Although it is apparently possible for E. coli to make trace amounts of intracellular galactose 6-phosphate (18) , presumably by phosphoenolpyruvate-dependent phosphorylation of galactose during membrane translocation (9, 15) , there is no known physiological role for galactose 6- phosphate in E. coli (18) . Since Using restriction endonuclease digestion, agarose gel or agarose-polyacrylamide gel electrophoresis, ligation and transformation, and selection on antibiotic-containing media as detailed previously (8, 8a), we made physical maps of several chimeric plasmids and their subclones (Fig. 1) . The Gal' phenotype, as tested on minimal medium (5) plus auxotrophic supplements and 0.5% galactose as a carbon source, was expressed by several subclones, including both orientations in the vector plasmid pBR322 (14) for the 5.06-kilobase (kb) insert and both orientations in the vector plasmid pACYC184 (4) for the 3.28-kb insert. We concluded from results with the 3.28-kb insert that genes encoding no more than 120,000 daltons of protein product were sufficient for expression of the Gal' phenotype. Miniceli analysis, performed as previously described (8) , indicated that at least three major proteins of approximate sizes 40,000, 16,000, and 14,000 daltons were encoded by the 3.28-kb insert (data not shown).
However, the expression of the Gal' phenotype was not optimal in our clones. When strain X1849 (8) , an E. coli K-12 strain with the A(galuvrB)47 mutation (which deletes the galK, -T, and -E genes), contained a recombinant plasmid, pYA501, carrying the 5.06-kb insert, its doubling time on galactose minimal medium was 6.5 to 8.5 h, whereas on glucose minimal medium the doubling time was about 3 h. Such results implied that pYA501 did not specify enzymes analogous to the galE and galU gene products, UDP-galactose 4-epimerase (EC 2.7.7.12) and glucose 1-phosphate uridylyl transferase (EC 2.7.7.10).
The second line of evidence was from indirect testing for cell surface galactose moieties which are synthesized from Leloir pathway intermediates. For instance, an E. coli strain with a galKTE deletion lacks galactose in the lipopolysaccharide core, due to absence of UDP-galactose synthesis, and the strain becomes resistant to bacteriophage U3 (19) and sensitive to bacteriophage C21 (2, 16); in the case of strain X1849, this phage sensitivity phenotype was not affected by introducing pYA501. Also, when tested at both 30 and 42°C in the presence of Mg2+ and cycloserine (12) , there was no evidence of colanic acid exopolysaccharide biosynthesis (which requires UDP-galactose) by strain X1849 containing one of the Gal+ recombinant plasmids.
Third, when the presence of the Leloir pathway enzymes was tested directly, using assays described by Postma (13) 
